FP-1039 (FGFR1:Fc), a soluble FGFR1 receptor antagonist, inhibits tumor growth and angiogenesis
Year: 2007
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: Five Prime Therapeutics (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2270120907
